Loading organizations...
Sherwood Ventures operates as a single family office, strategically investing in early-stage life sciences companies. The firm focuses on identifying and supporting ventures within the biomedical technology sector that develop novel solutions for debilitating conditions. Its investment approach prioritizes scientific innovation and significant advancements in medical treatment and patient care.
Established in 2021 and headquartered in Boston, Massachusetts, Sherwood Ventures was founded by Charles Sherwood. The firm was conceived with the understanding that nascent life science companies require dedicated capital to translate groundbreaking research into tangible therapeutic and technological solutions for critical health challenges.
The firm partners with companies committed to enhancing human health and extending longevity through scientific discovery. Sherwood Ventures' long-term vision centers on enabling transformative medical breakthroughs, ultimately improving the quality of life for individuals globally. It aims to be a foundational partner in the evolution of critical healthcare innovations.
Sherwood Ventures has 1 tracked investment across 1 company. The latest tracked deal is $2.3M Seed in Remedium Bio in August 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 16, 2022 | Remedium Bio | $2.3M Seed | Sherwood Ventures | Angel Star Ventures, Apis Health Angels, Guindy Alumni Angels, Longevity Tech Fund, MicroVentures, Primo Medical Group |